In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bromazepam Roche Brand Drug Master File in Korea (Bromazepam Roche Brand KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bromazepam Roche Brand. The MFDS reviews the Bromazepam Roche Brand KDMF as part of the drug registration process and uses the information provided in the Bromazepam Roche Brand KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bromazepam Roche Brand KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bromazepam Roche Brand API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bromazepam Roche Brand suppliers with KDMF on PharmaCompass.